UniProt ID | T2FB_HUMAN | |
---|---|---|
UniProt AC | P13984 | |
Protein Name | General transcription factor IIF subunit 2 | |
Gene Name | GTF2F2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 249 | |
Subcellular Localization | Nucleus . | |
Protein Description | TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation. This subunit shows ATP-dependent DNA-helicase activity.. | |
Protein Sequence | MAERGELDLTGAKQNTGVWLVKVPKYLSQQWAKASGRGEVGKLRIAKTQGRTEVSFTLNEDLANIHDIGGKPASVSAPREHPFVLQSVGGQTLTVFTESSSDKLSLEGIVVQRAECRPAASENYMRLKRLQIEESSKPVRLSQQLDKVVTTNYKPVANHQYNIEYERKKKEDGKRARADKQHVLDMLFSAFEKHQYYNLKDLVDITKQPVVYLKEILKEIGVQNVKGIHKNTWELKPEYRHYQGEEKSD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAERGELDL ------CCCCCCCCC | 18.39 | 19413330 | |
10 | Phosphorylation | ERGELDLTGAKQNTG CCCCCCCCCCCCCCC | 34.46 | - | |
13 | Ubiquitination | ELDLTGAKQNTGVWL CCCCCCCCCCCCEEE | 45.48 | 21890473 | |
22 | Ubiquitination | NTGVWLVKVPKYLSQ CCCEEEEECHHHHHH | 51.12 | 19608861 | |
22 | Acetylation | NTGVWLVKVPKYLSQ CCCEEEEECHHHHHH | 51.12 | 19608861 | |
25 | Sumoylation | VWLVKVPKYLSQQWA EEEEECHHHHHHHHH | 62.91 | - | |
25 | Ubiquitination | VWLVKVPKYLSQQWA EEEEECHHHHHHHHH | 62.91 | - | |
25 | Acetylation | VWLVKVPKYLSQQWA EEEEECHHHHHHHHH | 62.91 | 25953088 | |
25 | Sumoylation | VWLVKVPKYLSQQWA EEEEECHHHHHHHHH | 62.91 | - | |
33 | Ubiquitination | YLSQQWAKASGRGEV HHHHHHHHHCCCCCC | 39.88 | 19608861 | |
33 | Acetylation | YLSQQWAKASGRGEV HHHHHHHHHCCCCCC | 39.88 | 19608861 | |
33 | Methylation | YLSQQWAKASGRGEV HHHHHHHHHCCCCCC | 39.88 | 19608861 | |
35 | Phosphorylation | SQQWAKASGRGEVGK HHHHHHHCCCCCCCE | 28.46 | - | |
37 | Methylation | QWAKASGRGEVGKLR HHHHHCCCCCCCEEE | 35.29 | - | |
42 | Acetylation | SGRGEVGKLRIAKTQ CCCCCCCEEEEEECC | 39.50 | 23749302 | |
71 | Acetylation | NIHDIGGKPASVSAP CHHHCCCEECCCCCC | 32.00 | 23749302 | |
71 | Ubiquitination | NIHDIGGKPASVSAP CHHHCCCEECCCCCC | 32.00 | 21890473 | |
74 | Phosphorylation | DIGGKPASVSAPREH HCCCEECCCCCCCCC | 25.73 | 22210691 | |
76 | Phosphorylation | GGKPASVSAPREHPF CCEECCCCCCCCCCE | 30.02 | 20068231 | |
87 | Phosphorylation | EHPFVLQSVGGQTLT CCCEEEEECCCEEEE | 20.69 | - | |
124 | Phosphorylation | RPAASENYMRLKRLQ CCCCCHHHHHHEECC | 4.60 | 25884760 | |
135 | Phosphorylation | KRLQIEESSKPVRLS EECCCCCCCCCCCHH | 30.76 | 29083192 | |
136 | Phosphorylation | RLQIEESSKPVRLSQ ECCCCCCCCCCCHHH | 44.23 | 25159151 | |
137 | Acetylation | LQIEESSKPVRLSQQ CCCCCCCCCCCHHHH | 57.73 | 19608861 | |
137 | Ubiquitination | LQIEESSKPVRLSQQ CCCCCCCCCCCHHHH | 57.73 | 21906983 | |
142 | Phosphorylation | SSKPVRLSQQLDKVV CCCCCCHHHHHCCEE | 12.81 | 17525332 | |
147 | Ubiquitination | RLSQQLDKVVTTNYK CHHHHHCCEEECCCC | 47.39 | 21890473 | |
150 | Phosphorylation | QQLDKVVTTNYKPVA HHHCCEEECCCCCCC | 16.59 | 28152594 | |
151 | Phosphorylation | QLDKVVTTNYKPVAN HHCCEEECCCCCCCC | 25.58 | 28152594 | |
153 | Phosphorylation | DKVVTTNYKPVANHQ CCEEECCCCCCCCCC | 17.99 | 28152594 | |
154 | Ubiquitination | KVVTTNYKPVANHQY CEEECCCCCCCCCCC | 34.78 | 21890473 | |
154 | Acetylation | KVVTTNYKPVANHQY CEEECCCCCCCCCCC | 34.78 | 23954790 | |
154 | Malonylation | KVVTTNYKPVANHQY CEEECCCCCCCCCCC | 34.78 | 26320211 | |
161 | Phosphorylation | KPVANHQYNIEYERK CCCCCCCCCEEEEEC | 15.57 | 28152594 | |
165 | Phosphorylation | NHQYNIEYERKKKED CCCCCEEEEECHHHC | 19.76 | 28152594 | |
180 | 2-Hydroxyisobutyrylation | GKRARADKQHVLDML CHHHHHHHHHHHHHH | 41.12 | - | |
189 | Phosphorylation | HVLDMLFSAFEKHQY HHHHHHHHHHHHHCC | 28.25 | 24719451 | |
193 | Acetylation | MLFSAFEKHQYYNLK HHHHHHHHHCCCCHH | 29.56 | 21466224 | |
196 | Phosphorylation | SAFEKHQYYNLKDLV HHHHHHCCCCHHHHH | 8.27 | 28064214 | |
197 | Phosphorylation | AFEKHQYYNLKDLVD HHHHHCCCCHHHHHH | 13.88 | 28102081 | |
200 | Ubiquitination | KHQYYNLKDLVDITK HHCCCCHHHHHHCCC | 45.43 | 21890473 | |
207 | 2-Hydroxyisobutyrylation | KDLVDITKQPVVYLK HHHHHCCCCCCHHHH | 53.60 | - | |
218 | Ubiquitination | VYLKEILKEIGVQNV HHHHHHHHHHCCCCC | 53.61 | - | |
226 | Ubiquitination | EIGVQNVKGIHKNTW HHCCCCCCCCCCCCE | 60.75 | - | |
236 | Ubiquitination | HKNTWELKPEYRHYQ CCCCEEECCHHCCCC | 25.04 | - | |
236 | Sumoylation | HKNTWELKPEYRHYQ CCCCEEECCHHCCCC | 25.04 | - | |
236 | Sumoylation | HKNTWELKPEYRHYQ CCCCEEECCHHCCCC | 25.04 | - | |
239 | Phosphorylation | TWELKPEYRHYQGEE CEEECCHHCCCCCCC | 15.95 | 26074081 | |
242 | Phosphorylation | LKPEYRHYQGEEKSD ECCHHCCCCCCCCCC | 14.82 | 26074081 | |
248 | Phosphorylation | HYQGEEKSD------ CCCCCCCCC------ | 52.40 | 28176443 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of T2FB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of T2FB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of T2FB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HTSF1_HUMAN | HTATSF1 | physical | 10454543 | |
RPAB1_HUMAN | POLR2E | physical | 11278533 | |
T2EB_HUMAN | GTF2E2 | physical | 11113176 | |
RPB1_HUMAN | POLR2A | physical | 17643375 | |
RPB2_HUMAN | POLR2B | physical | 17643375 | |
RPB7_HUMAN | POLR2G | physical | 17643375 | |
RPAB3_HUMAN | POLR2H | physical | 17643375 | |
CTDP1_HUMAN | CTDP1 | physical | 17643375 | |
BAG6_HUMAN | BAG6 | physical | 17643375 | |
MED29_HUMAN | MED29 | physical | 17643375 | |
T2FA_HUMAN | GTF2F1 | physical | 7827505 | |
TAF10_HUMAN | TAF10 | physical | 10373431 | |
TAF5_HUMAN | TAF5 | physical | 10373431 | |
TAF4_HUMAN | TAF4 | physical | 10373431 | |
TF2B_HUMAN | GTF2B | physical | 16878124 | |
HMGA1_HUMAN | HMGA1 | physical | 18850631 | |
RL27A_HUMAN | RPL27A | physical | 20195357 | |
TC1D2_HUMAN | TCTEX1D2 | physical | 20195357 | |
U5S1_HUMAN | EFTUD2 | physical | 22863883 | |
SH3G1_HUMAN | SH3GL1 | physical | 22863883 | |
GLYC_HUMAN | SHMT1 | physical | 22863883 | |
SRRT_HUMAN | SRRT | physical | 26344197 | |
SPT4H_HUMAN | SUPT4H1 | physical | 26344197 | |
SPT5H_HUMAN | SUPT5H | physical | 26344197 | |
KLF5_HUMAN | KLF5 | physical | 9089417 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-22; LYS-33 AND LYS-137, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248, AND MASSSPECTROMETRY. |